Author  
Place of duty  
Title   소화기종양의 종양지표로서 CEA , CA19-9 CA125 에 관한 연구 ( CEA , CA19-9 and CA125 in Patients with Gastrointestinal Carcinoma )
Publicationinfo   1992 Jan; 024(05): 647-656.
Key_word   Tumor marker, Gastrointestinal cancer
Full-Text  
Abstract   Serum concentration of CEA, CA19-9 and CA125 were investigated to analyze the clinical significance of these tumor markers in 686 patients with gastrointestinal carcinoma, who were managed at the Departments of Surgery and Internal Medicine, Keimyung University Dongsan Hospital during 2 years from Nov. 1989 to Nov. 1991. The results were as following: 1) The positivity of the tumor marker was higher with CEA than CA19-9 and CA125 in pa- tients with gastric and colorectal carcinoma and with CA19-9 than CEA and CA125 in patients with pancreatic and biliary carcinoma. 2) Combined tumor marker studies were more sensitive than single tests and combination of CEA and CA19-9 showed higher sensitivity than other combinations for gastrointestinal carcinoma. 3) There were no significant correlations between the differentiation of the tumor and serum concentration of the tumor marker in patients with gastric and colorectal carcinoma, except mucinous type of gastric carcinoma, which showed significantly higher level of CA19-9. 4) CA19-9 and CEA showed higher sensitivity than the others in patients with recurred gas- tric and colorectal carcinoms, respectively. 5) Mean serum level of CA19-9 was 18.3+-15.8 U/ml with positivity of 0% in patients with chronic pancreatitis in contrast to 640.1+- 507.8 U/ml and 76% in patients with pancreatic carcinomas.
저 자   김형태(Hyung Tae Kim),손수상(Soo Sang Sohn),강중신(Joong Shin Kang)